home / stock / awkn:cc / awkn:cc news

AWKN:CC News and Press, AWAKN LIFE SCIENCES CORP. From 04/28/23

Stock Information
Company Name: AWAKN LIFE SCIENCES CORP.
Stock Symbol: AWKN:CC
Market: AQNC
Website: awaknlifesciences.com
Menu
AWKN:CC AWKN:CC Quote AWKN:CC Short AWKN:CC News AWKN:CC Articles AWKN:CC Message Board
Get AWKN:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
AWKN:CC - Awakn Life Sciences Reports Q4 2023 and Annual Results

Annual Revenue Increased by 534% Toronto, Ontario--(Newsfile Corp. - April 28, 2023) -   Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), annou...
AWKN:CC - IIROC Trade Resumption - AWKN

IIROC Trade Resumption - AWKN Canada NewsWire TORONTO , April 26, 2023 /CNW/ - Trading resumes in: Company: AWAKN LIFE SCIENCES CORP. NEO Exchange Symbol: AWKN All Issues: Yes Resumption (ET): 9:30 AM IIROC can make a decision to impose a temp...

AWKN:CC - Awakn Life Sciences Announces Private Placement

Toronto, Ontario--(Newsfile Corp. - April 26, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (the " Company "), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is pleased to announce a non-brokered p...

AWKN:CC - IIROC Trading Halt - AWKN

IIROC Trading Halt - AWKN Canada NewsWire TORONTO , April 26, 2023 /CNW/ - The following issues have been halted by IIROC: Company: AWAKN LIFE SCIENCES CORP. NEO Exchange Symbol : AWKN All Issues: Yes Reason: Pending News Halt Time (ET): 8:03 AM...
AWKN:CC - Awakn Life Sciences Signs Collaboration Agreement with University of Exeter for Upcoming Phase III Trial

Phase III Trial Will Assess Ketamine-Assisted Therapy for the Treatment of Severe Alcohol Use Disorder Toronto, Ontario--(Newsfile Corp. - April 18, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addicti...

AWKN:CC - Awakn Life Sciences Increases Ownership of Awakn Bristol to 100% and Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - April 12, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), is today providing a corporate update. Dr. Be...

AWKN:CC - Awakn Life Sciences Signs Its Fourth Licensing Partnership Agreement in North America, and First in California

Partnership is Awakn's first with a dedicated addiction treatment clinic, Ken Starr MD Wellness Group Toronto, Ontario--(Newsfile Corp. - February 28, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ('Awakn'), a biotechnology company developing therapeutics to treat addic...
AWKN:CC - Awakn Life Sciences Signs Its First Licensing Partnership Agreement in Europe

Awakn Will License its Protocols for Treating Addiction and Mental Health to a Healthcare Consortium to Help Accelerate Their Development of a Chain of Clinics in Portugal Toronto, Ontario--(Newsfile Corp. - February 21, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("A...

AWKN:CC - Awakn Life Sciences Announces the Opening of Its Fourth Clinic

Awakn Clinics Trondheim is its second clinic in Norway Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Diso...

AWKN:CC - Awakn Life Sciences Initiates Feasibility Study for MDMA Using Catalent's Zydis Orally Disintegrating Tablet (ODT) Technology

Toronto, Ontario--(Newsfile Corp. - February 9, 2023) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn"), a biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD), today announced it has initiated a feasibilit...
Previous 10 Next 10